|
Re: Share value
|
1
|
Zenith Epigenetics
|
Nov 22, 2017 04:19PM
|
|
Re: Happy Turkey Day...
|
2
|
Resverlogix Corp.
|
Nov 22, 2017 02:43PM
|
|
Analyst coverage and more promo coverage
|
7
|
Resverlogix Corp.
|
Nov 18, 2017 06:03PM
|
|
Re: Zenith share issue
|
6
|
Zenith Epigenetics
|
Nov 15, 2017 03:30PM
|
|
Re: Zenith share issue
|
6
|
Zenith Epigenetics
|
Nov 15, 2017 12:39PM
|
|
Re: Zenith share issue
|
6
|
Zenith Epigenetics
|
Nov 14, 2017 01:11PM
|
|
Re: Zenith Q4 2017 Events
|
3
|
Zenith Epigenetics
|
Nov 13, 2017 12:49PM
|
|
Re: BIO-Europe Presentation is up
|
1
|
Resverlogix Corp.
|
Nov 07, 2017 12:36PM
|
|
Re: Is It Possible That
|
2
|
Resverlogix Corp.
|
Nov 01, 2017 01:46PM
|
|
Re: More Than Just DSMB Green Light
|
4
|
Resverlogix Corp.
|
Nov 01, 2017 01:36PM
|
|
DSMB 5 postitive recomendation
|
3
|
Resverlogix Corp.
|
Nov 01, 2017 08:21AM
|
|
Re: No trading yet on the TSX
|
6
|
Resverlogix Corp.
|
Oct 27, 2017 11:35AM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
4
|
Zenith Epigenetics
|
Oct 25, 2017 04:36PM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
4
|
Zenith Epigenetics
|
Oct 24, 2017 12:04PM
|
|
RVX announces first right of refusal for license deal in the US
|
4
|
Resverlogix Corp.
|
Oct 24, 2017 07:48AM
|
|
Re: Q4 2017 Events
|
3
|
Resverlogix Corp.
|
Oct 21, 2017 11:55AM
|
|
Re: Zenith Announces Webcast Presentation at the BIO Investor Forum
|
3
|
Zenith Epigenetics
|
Oct 16, 2017 03:31PM
|
|
Re: The positive view
|
5
|
Resverlogix Corp.
|
Oct 13, 2017 01:11PM
|
|
Re: Hepalink WERE HALTED!!
|
1
|
Resverlogix Corp.
|
Oct 13, 2017 09:28AM
|
|
Re: Number of shares to compute the price per share
|
3
|
Zenith Epigenetics
|
Oct 04, 2017 08:32AM
|
